Health Care Law News and Insights

Short-Term Government Funding Legislation Includes Health Policy Extenders, Drug Rebate Definition Change, DSH Policies

Published: Oct 04, 2019
|
On September 26, 2019 the Senate approved H.R. 4378, the Continuing Appropriations Act, 2020, and Health Extenders Act of 2019, which would fund the federal government through November 21, 2019. The House has already approved the legislation, and President Trump is expected to sign the bill. The legislation includes a number...

Read More

Compounding Pharmacy And Private Equity Firm Owner Agree To $21 Million Settlement To Resolve FCA Allegations

Published: Sep 26, 2019
|
By
The Department of Justice (DOJ) recently announced that it has agreed to a $21.36 million settlement with compounding pharmacy Diabetic Care Rx LLC d/b/a Patient Care America (PCA), private equity firm Riordan, Lewis & Haden Inc. (RLH), and two PCA executives to resolve a pending False Claims Act (FCA) case. As discussed...

Read More

Eleventh Circuit Rules In AseraCare Case That Disagreements In Clinical Judgment, Without Objective Falsity, Do Not Prove Fraud Under The FCA

Published: Sep 16, 2019
|
By
On Monday, the U.S. Court of Appeals for the Eleventh Circuit issued its long-awaited and closely watched decision in United States v. AseraCare Inc.. The court ruled that a claim cannot be deemed false under the False Claims Act (FCA) based on a difference in clinical judgment. Instead, there must be...

Read More
Go to Top